<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02078765</url>
  </required_header>
  <id_info>
    <org_study_id>BGH-2-2013</org_study_id>
    <secondary_id>M-2013-303-13</secondary_id>
    <nct_id>NCT02078765</nct_id>
  </id_info>
  <brief_title>Nocturnal Blood Pressure and Hypertension - Central and Peripheral 24-h Blood Pressure.</brief_title>
  <acronym>HOSA</acronym>
  <official_title>Nocturnal Blood Pressure in Hypertension, Obstructive Sleep Apnea and Healthy Subjects - Central and Peripheral 24-h Blood Pressure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erling Bjerregaard Pedersen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Regional Hospital Holstebro</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A new study have shown that high night time blood pressure (BP) and/or non-dipping (lack of&#xD;
      fall in BP during night time) is a strong predictor for the risk of cardiovascular disease&#xD;
      and mortality in patients with hypertension. Three factors seem to affect the night time BP:&#xD;
      chronic kidney disease, obstructive sleep apnea (OSA) and the way ambulatory blood pressure&#xD;
      is monitored.&#xD;
&#xD;
      Hypothesis:&#xD;
&#xD;
      Central 24-h blood pressure monitoring is a better way of monitoring blood pressure than&#xD;
      conventional peripheral monitoring.&#xD;
&#xD;
      In hypertension, chronic kidney disease and obstructive sleep apnea (OSA) the night time&#xD;
      blood pressure is elevated, and is OSA the elevation is correlated to the severity of OSA.&#xD;
&#xD;
      In OSA the kidneys handling of salt and water is disturbed. In OSA there is disturbances in&#xD;
      hormonal balance.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      75 patients with hypertension and chronic kidney disease (CKD I-II) and 75 healthy subjects&#xD;
      is examined with both central and peripheral 24 hours blood pressure monitoring, 1 night home&#xD;
      polygraphy to determine whether the subject has obstructive sleep apnea (OSA), and if so the&#xD;
      degree (apnea hypopnea index, AHI), blood and urine samples to determine levels of urine&#xD;
      aquaporine2 (u-AQP2), urine endothelial sodium channel (u-EnaC), plasma renin concentration&#xD;
      (PRC), plasma angiotensin II (p-AngII), plasma aldosterone (p-aldosterone), plasma&#xD;
      vasopressin (p-AVP) and plasma endothelin (p-endothelin).&#xD;
&#xD;
      Hypothesis:&#xD;
&#xD;
      Central 24-h BP monitoring provides another measure of daily fluctuations in blood pressure&#xD;
      than peripheral 24-h BP monitoring, because this measurement is painless and does not&#xD;
      interfere with activities in the daytime or night-time sleep.&#xD;
&#xD;
      In hypertension, chronic kidney disease and OSA the decease in nocturnal BP is lower than i&#xD;
      healthy subjects.&#xD;
&#xD;
      In OSA the decrease in the nocturnal BP is inversely correlated with the severity of OSA.&#xD;
&#xD;
      In OSA is the renal tubular absorption of water and sodium abnormal with increased tubular&#xD;
      absorption of water with AQP2 and of sodium by ENAC.&#xD;
&#xD;
      In OSA, there is increased activity of the renin-angiotensin-aldosterone system, increased&#xD;
      endothelin in plasma and increased vasopressin in plasma.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>decrease in central systolic blood pressure at night</measure>
    <time_frame>&lt; 24 hours</time_frame>
    <description>The difference in the decrease in systolic BP at night by peripheral 24-h BP between patients with hypertension and healthy subjects.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>decrease in central systolic blood pressure at night</measure>
    <time_frame>&lt; 24 hours</time_frame>
    <description>The difference in the decrease in systolic BP at night by the central 24-h BP between patients with hypertension and healthy subjects.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>difference i blood pressure levels throughout the day</measure>
    <time_frame>&lt; 24 hours</time_frame>
    <description>The difference in systolic blood pressure and diastolic blood pressure throughout the day, in the daytime and in nighttime between peripheral 24-h and central 24-h monitoring in both patients and healthy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The correlation between the decrease in nighttime BP on one side and severity of OSA and BP in the daytime on the other.</measure>
    <time_frame>&lt; 24 hours</time_frame>
    <description>The correlation between the decrease in nighttime BP on one side and severity of OSA and BP in the daytime on the other.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>u-AQP2 and u-ENac</measure>
    <time_frame>24 hours</time_frame>
    <description>In 24-h urine samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PRC, p-AngII, p-aldosterone, p-AVP, p-endothelin</measure>
    <time_frame>&lt; 1 hour</time_frame>
    <description>blood samples</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Hypertension</condition>
  <condition>Chronic Kidneys Disease</condition>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>hypertension</arm_group_label>
    <description>75 patients with hypertension and chronic kidney disease (CKD stage I-II)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy subjects</arm_group_label>
    <description>75 healthy subjects</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood, serum, urine&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Group 1: 75 patients with hypertension, recruited from another study in the Holstebro Area,&#xD;
        contacted by letter.&#xD;
&#xD;
        Group 2: healthy subjects are recruited though posters in public and private companies as&#xD;
        well as advertising in local media.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Group 1:&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Chronic kidney disease (CKD stage I and II), estimated glomerule filtration rate&#xD;
             (eGFR) 60-90 ml/min/1.73 m2 or eGFR&gt; 90 ml/min/1.73 m2 and proteinuria or other signs&#xD;
             of kidney damage.&#xD;
&#xD;
          -  Hypertension (BP by ambulatory or home blood pressure&gt; 135/85 mmHg, or consultation&#xD;
             blood pressure&gt; 140/90 mmHg).&#xD;
&#xD;
          -  Both men and women&#xD;
&#xD;
          -  55-70 years&#xD;
&#xD;
          -  A completed consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Lack of desire to participate&#xD;
&#xD;
          -  In the treatment of OSA&#xD;
&#xD;
          -  Malignant disease&#xD;
&#xD;
          -  Abuse of drugs or alcohol&#xD;
&#xD;
          -  Pregnant and breastfeeding&#xD;
&#xD;
          -  Incompensated heart failure&#xD;
&#xD;
          -  Atrial fibrillation&#xD;
&#xD;
          -  Liver disease (Alanine aminotransferase (ALT)&gt; 200)&#xD;
&#xD;
          -  Severe chronic obstructive pulmonary disease (COPD) (Forced expiratory volume in 1&#xD;
             second &lt;50% predicted)&#xD;
&#xD;
          -  eGFR &lt;60 ml/min/1.73 m2&#xD;
&#xD;
          -  Blood pressure difference between the right and left arm&gt; 10/10 mmHg&#xD;
&#xD;
        Group 2 - Healthy subjects&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy subjects men and women&#xD;
&#xD;
          -  age 55 - 70 years&#xD;
&#xD;
          -  Body mass index within the normal range, between 18.5 to 25.0 kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Arterial hypertension, ambulatory blood pressure&gt; 130 mmHg systolic and / or 80 mmHg&#xD;
             diastolic.&#xD;
&#xD;
               -  a history or clinical signs of cardial, pulmonary, hepato, renal, endocrine,&#xD;
                  cerebral or neoplastic disorders&#xD;
&#xD;
               -  Alcohol abuse, ie. &gt; 14 drinks / week for women and&gt; 21/uge for men&#xD;
&#xD;
               -  Substance abuse&#xD;
&#xD;
               -  Medical treatment apart from oral contraceptives&#xD;
&#xD;
               -  Smoking&#xD;
&#xD;
               -  Pregnancy or breastfeeding&#xD;
&#xD;
               -  Lack of desire to participate&#xD;
&#xD;
               -  Clinically significant, discrepant results of blood or urine sample at inclusion&#xD;
                  study (B-hemoglobin and B-White blood cell count, p-sodium, p-potassium,&#xD;
                  p-creatinine, p-ALT, p-bilirubin , p-Alkaline phosphatase, p-cholesterol,&#xD;
                  p-albumin or b-glucose and urine for hematuria, albuminuria or glucosuria)&#xD;
&#xD;
               -  Clinically significant variations in the electrocardiogram&#xD;
&#xD;
               -  Blood Donation for the past month preceding the day on the first attempt sequence&#xD;
&#xD;
               -  Blood pressure difference between the right and left arm&gt; 10/10 mmHg.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Medical Research and Medicine, Holstebro Regional Hospital</name>
      <address>
        <city>Holstebro</city>
        <zip>7500</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <study_first_submitted>March 1, 2014</study_first_submitted>
  <study_first_submitted_qc>March 1, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2014</study_first_posted>
  <last_update_submitted>October 8, 2014</last_update_submitted>
  <last_update_submitted_qc>October 8, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 9, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Regional Hospital Holstebro</investigator_affiliation>
    <investigator_full_name>Erling Bjerregaard Pedersen</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>hypertension</keyword>
  <keyword>chronic kidneys disease</keyword>
  <keyword>obstructive sleep apnea</keyword>
  <keyword>24-h blood pressure</keyword>
  <keyword>central blood pressure</keyword>
  <keyword>peripheral blood pressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

